Virulent Marek's disease virus generated from infectious bacterial artificial chromosome clones with complete DNA sequence and the implication of viral genetic homogeneity in pathogenesis

Journal of General Virology

Volumn 92, Issue 3, 2011, Pages 598-607

  Niikura, Masahiro ^a,b,c   Kim, Taejoong ^a,d   Silva, Robert F ^a   Dodgson, Jerry ^b   Cheng, Hans H ^a  

^a AGRICULTURAL RESEARCH SERVICE   (United States)

^b Michigan State University ^*  (United States)

^c SIMON FRASER UNIVERSITY   (Canada)

^d UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE;

ANIMAL CELL; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CELL LINE; CHICKEN; CLONE; CONTROLLED STUDY; COSMID; DISEASE PREDISPOSITION; DNA SEQUENCE; EMBRYO; GENE DELETION; GENETIC TRANSFECTION; INOCULATION; MARDIVIRUS; MAREK DISEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PATHOGENESIS; PRIORITY JOURNAL; VIRUS GENOME; VIRUS REPLICATION; VIRUS VIRULENCE;

ANIMALS; CELL LINE; CHICKENS; CHROMOSOMES, ARTIFICIAL, BACTERIAL; CLONING, MOLECULAR; DNA, VIRAL; MARDIVIRUS; MAREK DISEASE; MOLECULAR SEQUENCE DATA; PLAQUE ASSAY; SEQUENCE ANALYSIS, DNA; TRANSFECTION; VIRAL LOAD; VIRULENCE;

BACTERIA (MICROORGANISMS); GALLID HERPESVIRUS 2; GALLUS GALLUS;

EID: 79951777993     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.026864-0     Document Type: Article

References (37)

1. Baigent, S. J., Petherbridge, L. J., Smith, L. P., Zhao, Y., Chesters, P. M. & Nair, V. K. (2006). Herpesvirus of turkey reconstituted from bacterial artificial chromosome clones induces protection against Marek's disease. J Gen Virol 87, 769-776.
2. Calnek, B. W. (2001). Pathogenesis of Marek's disease virus infection. In Marek's Disease (Current Topics in Microbiology and Immunology vol. 255), pp. 57-90. Edited by K. Hirai. Berlin, Heidelberg, New York: Springer-Verlag.
3. Cho, B. R. (1978). An improved method for extracting cell-free herpesviruses of Marek's disease and turkeys from infected cell cultures. Avian Dis 22, 170-176.
4. Cox, E., Reddy, S., Iofin, I. & Cohen, J. I. (1998). Varicella-zoster virus ORF57, unlike its pseudorabies virus UL3.5 homolog, is dispensable for viral replication in cell culture. Virology 250, 205-209. (Pubitemid 28471776)
5. Cui, X., Lee, L. F., Reed, W. M., Kung, H. J. & Reddy, S. M. (2004). Marek's disease virus-encoded vIL-8 gene is involved in early cytolytic infection but dispensable for establishment of latency. J Virol 78, 4753-4760. (Pubitemid 38501096)
6. Dargan, D. J., Douglas, E., Cunningham, C., Jamieson, F., Stanton, R. J., Baluchova, K., McSharry, B. P., Tomasec, P., Emery, V. C. & other authors (2010). Sequential mutations associated with adaptation of human cytomegalovirus to growth in cell culture. J Gen Virol 91, 1535-1546.
7. Dean, H. J. & Cheung, A. K. (1993). A 39 coterminal gene cluster in pseudorabies virus contains herpes simplex virus UL1, UL2, and UL3 gene homologs and a unique UL3.5 open reading frame. J Virol 67, 5955-5961. (Pubitemid 23277506)
8. Drake, J. W. & Hwang, C. B. (2005). On the mutation rate of herpes simplex virus type 1. Genetics 170, 969-970. (Pubitemid 40980695)
9. Drake, J. W., Charlesworth, B., Charlesworth, D. & Crow, J. F. (1998). Rates of spontaneous mutation. Genetics 148, 1667-1686. (Pubitemid 28180696)
10. Ferrin, L. J. & Camerini-Otero, R. D. (1991). Selective cleavage of human DNA: RecA-assisted restriction endonuclease (RARE) cleavage. Science 254, 1494-1497. (Pubitemid 21917486)
11. Fuchs, W. & Mettenleiter, T. C. (1996). DNA sequence and transcriptional analysis of the UL1 to UL5 gene cluster of infectious laryngotracheitis virus. J Gen Virol 77, 2221-2229. (Pubitemid 26316093)
12. Fuchs, W., Klupp, B. G., Granzow, H., Rziha, H. J. & Mettenleiter, T. C. (1996). Identification and characterization of the pseudorabies virus UL3.5 protein, which is involved in virus egress. J Virol 70, 3517-3527. (Pubitemid 26157331)
13. Fuchs, W., Granzow, H., Klupp, B. G., Karger, A., Michael, K., Maresch, C., Klopfleisch, R. & Mettenleiter, T. C. (2007). Relevance of the interaction between alphaherpesvirus UL3.5 and UL48 proteins for virion maturation and neuroinvasion. J Virol 81, 9307-9318. (Pubitemid 47311473)
14. Gimeno, I. M., Witter, R. L., Hunt, H. D., Reddy, S. M., Lee, L. F. & Silva, R. F. (2005). The pp38 gene of Marek's disease virus (MDV) is necessary for cytolytic infection of B cells and maintenance of the transformed state but not for cytolytic infection of the feather follicle epithelium and horizontal spread of MDV. J Virol 79, 4545-4549. (Pubitemid 40388394)
15. Gimeno, I. M., Cortes, A. L. & Silva, R. F. (2008). Load of challenge Marek's disease virus DNA in blood as a criterion for early diagnosis of Marek's disease tumors. Avian Dis 52, 203-208. (Pubitemid 351883732)
16. Himly, M., Foster, D. N., Bottoli, I., Iacovoni, J. S. & Vogt, P. K. (1998). The DF-1 chicken fibroblast cell line: transformation induced by diverse oncogenes and cell death resulting from infection by avian leukosis viruses. Virology 248, 295-304. (Pubitemid 28417716)
17. S2 is nonessential. J Virol 84, 7911-7916.
18. Jarosinski, K. W., Margulis, N. G., Kamil, J. P., Spatz, S. J., Nair, V. K. & Osterrieder, N. (2007). Horizontal transmission of Marek's disease virus requires US2, the UL13 protein kinase, and gC. J Virol 81, 10575-10587. (Pubitemid 47463331)
19. Khattar, S. K., van Drunen Littel-van den Hurk, S., Babiuk, L. A. & Tikoo, S. K. (1995). Identification and transcriptional analysis of a 3′- coterminal gene cluster containing UL1, UL2, UL3, and UL3.5 open reading frames of bovine herpesvirus-1. Virology 213, 28-37.
20. Kishi, M., Bradley, G., Jessip, J., Tanaka, A. & Nonoyama, M. (1991). Inverted repeat regions of Marek's disease virus DNA possess a structure similar to that of the a sequence of herpes simplex virus DNA and contain host cell telomere sequences. J Virol 65, 2791-2797.
21. Lee, L. F., Lupiani, B., Silva, R. F., Kung, H. J. & Reddy, S. M. (2008). Recombinant Marek's disease virus (MDV) lacking the Meq oncogene confers protection against challenge with a very virulent plus strain of MDV. Vaccine 26, 1887-1892.
22. Lupiani, B., Lee, L. F., Cui, X., Gimeno, I., Anderson, A., Morgan, R. W., Silva, R. F., Witter, R. L., Kung, H. J. & Reddy, S. M. (2004). Marek's disease virus-encoded Meq gene is involved in transformation of lymphocytes but is dispensable for replication. Proc Natl Acad Sci U S A 101, 11815-11820. (Pubitemid 39095377)
23. Mao, W., Niikura, M., Silva, R. F. & Cheng, H. H. (2008). Quantitative evaluation of viral fitness due to a single nucleotide polymorphism in the Marek's disease virus UL41 gene via an in vitro competition assay. J Virol Methods 148, 125-131.
24. Montgomery, A. & Centifanto, Y. (1989). Heterogeneity within an HSV-1 wild-type strain and its importance in pathogenesis. Proc Soc Exp Biol Med 191, 362-369. (Pubitemid 19253898)
25. Niikura, M., Dodgson, J. & Cheng, H. (2006). Direct evidence of host genome acquisition by the alphaherpesvirus Marek's disease virus. Arch Virol 151, 537-549.
26. Osterrieder, N., Kamil, J. P., Schumacher, D., Tischer, B. K. & Trapp, S. (2006). Marek's disease virus: from miasma to model. Nat Rev Microbiol 4, 283-294.
27. Petherbridge, L., Brown, A. C., Baigent, S. J., Howes, K., Sacco, M. A., Osterrieder, N. & Nair, V. K. (2004). Oncogenicity of virulent Marek's disease virus cloned as bacterial artificial chromosomes. J Virol 78, 13376-13380. (Pubitemid 39507844)
28. Petherbridge, L., Xu, H., Zhao, Y., Smith, L. P., Simpson, J., Baigent, S. & Nair, V. (2009). Cloning of Gallid herpesvirus 3 (Marek's disease virus serotype-2) genome as infectious bacterial artificial chromosomes for analysis of viral gene functions. J Virol Methods 158, 11-17.
29. Reddy, S. M., Lupiani, B., Gimeno, I. M., Silva, R. F., Lee, L. F. & Witter, R. L. (2002). Rescue of a pathogenic Marek's disease virus with overlapping cosmid DNAs: use of a pp38 mutant to validate the technology for the study of gene function. Proc Natl Acad Sci U S A 99, 7054-7059. (Pubitemid 34526254)
30. Sambrook, J., Fritsch, E. F. & Maniatis, T. (1989). Molecular Cloning, 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
31. Schumacher, D., Tischer, B. K., Fuchs, W. & Osterrieder, N. (2000). Reconstitution of Marek's disease virus serotype 1 (MDV-1) from DNA cloned as a bacterial artificial chromosome and characterization of a glycoprotein B-negative MDV-1 mutant. J Virol 74, 11088-11098. (Pubitemid 32223974)
32. Silva, R. F., Reddy, S. M. & Lupiani, B. (2004). Expansion of a unique region in the Marek's disease virus genome occurs concomitantly with attenuation but is not sufficient to cause attenuation. J Virol 78, 733-740. (Pubitemid 38067595)
33. Spatz, S. J. (2010). Accumulation of attenuating mutations in varying proportions within a high passage very virulent plus strain of Gallid herpesvirus type 2. Virus Res 149, 135-142.
34. Tulman, E. R., Afonso, C. L., Lu, Z., Zsak, L., Rock, D. L. & Kutish, G. F. (2000). The genome of a very virulent Marek's disease virus. J Virol 74, 7980-7988. (Pubitemid 30641642)
35. Witter, R. L. (2001). Protective efficacy of Marek's disease vaccine. In Marek's Disease (Current Topics in Microbiology and Immunology vol. 255), pp. 57-90. Edited by K. Hirai. Berlin, Heidelberg, New York: Springer-Verlag.
36. Yamamoto, H., Hattori, M., Ohashi, K., Sugimoto, C. & Onuma, M. (1995). Kinetic analysis of T cells and antibody production in chickens infected with Marek's disease virus. J Vet Med Sci 57, 945-946.
37. Zhao, Y., Petherbridge, L., Smith, L. P., Baigent, S. & Nair, V. (2008). Self-excision of the BAC sequences from the recombinant Marek's disease virus genome increases replication and pathogenicity. Virol J 5, 19.